Corbus Pharmaceuticals Holdings, Inc. (CRBP) Institutional Ownership

Ownership Summary

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) showed up in the 13F filings of 1 institutional investors as of June 2025.

• Their combined ownership stood at 0.0% of outstanding shares in June 2025, down from 0.0% in March 2025.
• They maintained total shares held in Corbus Pharmaceuticals Holdings by 0.0% from the prior quarter, while the number of investors in CRBP stayed flat year over year.
• Of these 1 funds, 0 grew their exposure to Corbus Pharmaceuticals Holdings, 0 cut back, and 1 maintained positions.
• In total, institutional investors held 0 shares in Corbus Pharmaceuticals Holdings as of June 2025, with no net change quarter on quarter, and with no net change year over year.
• As of June 30, 2025, Cormorant Asset Management, LP held the largest stake in Corbus Pharmaceuticals Holdings with 2.34Mn shares, accounting for 19.16% of total shares outstanding.
• Top purchasers of CRBP stock for the quarter ending June 2025 included VANGUARD CAPITAL MANAGEMENT LLC (734.11K), DIADEMA PARTNERS LP (439.96K), ORBIMED ADVISORS LLC (140.0K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (105.59K), Persistent Asset Partners Ltd (104.64K).
• Top sellers of CRBP stock for the quarter ending June 2025 included ADAR1 Capital Management, LLC (241.78K), ARMISTICE CAPITAL, LLC (172.0K), CITADEL ADVISORS LLC (116.13K), Assenagon Asset Management S.A. (102.71K), BALYASNY ASSET MANAGEMENT L.P. (68.11K).
• Business Quant data shows the 10 biggest positions in Corbus Pharmaceuticals Holdings as of June 2025 are held by Cormorant Asset Management, LP (2.34Mn), ORBIMED ADVISORS LLC (1.74Mn), Aberdeen Group plc (1.32Mn), VANGUARD CAPITAL MANAGEMENT LLC (734.11K), CITADEL ADVISORS LLC (727.06K), DIADEMA PARTNERS LP (439.96K), Stonepine Capital Management, LLC (383.46K), ARMISTICE CAPITAL, LLC (364.0K), RENAISSANCE TECHNOLOGIES LLC (347.0K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (333.42K).